12:14 PM EST - Labopharm Inc. : shares rose after the company said it sees ''a regulatory path forward'' despite the U.S. Food and Drug Administration's denial of its appeal against a previous decision on its once-daily formulation of painkiller tramadol. Labopharm Inc.
shares T.DDS are trading up 56 cents at $1.89.
